Event info
Date:07 Jun
Time:12.30 - 17.30
Venue:Ørestad, Copenhagen
Contact person
Sofia Norås

Sofia Norås

Project Manager

sn@mva.org

+45 2337 0040

Microbiome Signature Project: Project Outcomes and Future Outlook

Join the Microbiome Signature Project: Outcomes and Future Outlook event at Hubnordic in Ørestad, Copenhagen and learn more about recent investments and establishments in the region, meet international talent and for an exclusive presentation of a microbiome hub benchmarking study and a possible future microbiome platform for the Medicon Valley region.

The Microbiome Signature Project: Outcomes and Future Outlook event offers a place gathering the region’s leading microbiome scientists and companies, research talents and startups, key opinion leaders and funding partners.

Date: Tuesday 7 June 2022
Time: 12.30 – 17.30
Venue: Hubnordic, Hub 3 Auditorium, Arne Jacobsens Allé 13, 2300 Ørestad, Copenhagen

 

SIGN UP

Programme

10.00 – 12.30 Rising Stars in Medicon Valley Microbiome Research

This is an MVA Microbiome Network meeting organised in partnership with the Microbiome Signature Project, that will feature several up and coming researchers in Medicon Valley working on the microbiome.

Registration is required separately and the event is open to all. To find out more and register, please see the event page here.


12.30

Lunch & networking

13.30

Welcome
Anette Steenberg, CEO, Medicon Valley Alliance
Ulrika Ringdahl, Managing Director, Invest in Skåne
Nikolaj Lubanski, COO, Copenhagen Capacity

13.40

The Medicon Valley Ecosystem
Overarching trends in microbiome research in Medicon Valley over the past two years.
Sarah Lidé, Senior Strategy & Project Manager, Medicon Valley Alliance

13.55

Tapping into the Microbiome Potential
Investments and establishments in the Medicon Valley region
Camilla Münter, Investment Manager –  Life Sciences, Copenhagen Capacity
Micael Györei, Senior Investment Advisor – Life Sciences, Invest in Skåne
Ömer Özkan, CEO & Founder, Enbiosis Biotechnology

14.30

Joining a Leading Microbiome Hub
Why international talents join Medicon Valley
Dan Rosenberg, Strategy & Talent Acquisition Lead, Copenhagen Capacity
Trine Hodal, Head of Global HR Services, Chr. Hansen
Albert Palleja Caro, PhD, Bioinformatics Specialist, Clinical Microbiomics
Francesca Lanuza, EMEA & Global Regulatory Affairs Manager at Johnson & Johnson

15.05Break
15.30

Exploring the potential for a Medicon Valley Microbiome Research and Innovation Platform
Findings from a benchmarking study on microbiome research hubs in Europe and US
Panel discussion: Reflections on the findings from the microbiome hub benchmarking study, and the way ahead

Sarah Lidé, Senior Strategy & Project Manager, Medicon Valley Alliance
Arthur Krause, Consultant in the Global Strategy Group for Life Sciences, KPMG Switzerland
Dina Petranovic Nielsen, CPO & CSO, DTU Biosustain
Mani Arumugam, Associate Professor, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Kristine Koppelhus, Director of Scientific and Public Affairs, BioGaia

16.15

Conclusions & the Way Forward
Summary of the three-year project and how to keep momentum going forward

16.20Mingle and networking

 

More information including information about the speakers

 

About the Organisers 

The Microbiome Signature Project: Outcomes and Future Outlook event is organised by the Greater Copenhagen Microbiome Signature Project, which seeks to position the Medicon Valley area as a global centre for microbiome research. The three-year project aims to enhance collaboration, boost private investments in research and innovation, establish international research facilities and activities, and attract talent to both public and private funded research environments. The project is jointly managed and run by Medicon Valley Alliance, Copenhagen Capacity and Invest in Skåne, and is supported by Interreg Öresund-Kattegat-Skagerrak and Greater Copenhagen.

Organised by

 

In partnership with 
copenhagen capacity logo

 

Supported by
Interreg logo